文献速递肝病

1999至2018年中国非酒精性脂肪性肝病的流行病学特征

Epidemiological Features of NAFLD From 1999 to 2018 in China.
PubMed 文献 · Hepatology · 2020-01-01

该文采用系统综述与荟萃分析方法,总结过去二十年中国NAFLD的八项流行病学特征。数据显示NAFLD人群快速增长,尤其在年轻人群中;与美国人群相比,BMI和遗传风险存在明显种族差异;晚期肝病病因因生活方式西化和病毒性肝炎疫苗接种而改变;大量患者因诊断工具不足和缺乏有效药物而未确诊未治疗。

要点

  • 中国NAFLD患病率快速增长,年轻人群尤为突出。
  • 中国人群与美国人群在BMI和遗传风险上存在明显种族差异。
  • 大量NAFLD患者因诊断工具不足和缺乏有效药物而未确诊未治疗。

核心结论

  • 中国NAFLD患病率快速增长且年轻化,相关晚期肝病和疾病负担预计将大幅增加。

研究设计与样本

  • 采用系统综述与荟萃分析方法,总结1999至2018年中国NAFLD的八项流行病学特征。

主要发现

  • NAFLD人群快速增长,尤其在年轻人群中。
  • 与美国人群相比,中国人群BMI和NAFLD遗传风险存在明显种族差异。
  • 生活方式西化和病毒性肝炎疫苗接种使晚期肝病及其并发症病因发生改变。
  • 地区流行病学模式提示经济、环境和生活方式是疾病进展的关键因素。
  • 大量患者因诊断工具不足和缺乏有效药物而未确诊未治疗。

临床怎么用

  • 应重视年轻人群NAFLD的筛查与早期识别。
  • 制定管理策略时需考虑中国人群BMI和遗传风险的种族差异。
  • 需加强诊断工具开发与有效药物研究以应对大量未确诊未治疗患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China but has not received sufficient attention. NAFLD-related advanced liver disease and its mortality along with its overall disease burden are expected to increase substantially. There is thus an imperative need to clarify the epidemiological features of NAFLD to guide a holistic approach to management. We summarize eight epidemiological features of NAFLD in China over the past two decades using systematic review and meta-analysis methodology. Our data reveal a rapid growth in the NAFLD population, especially among younger individuals. Importantly, there is a strong ethnic difference in body mass index (BMI) and genetic risk of NAFLD compared with the US population. The etiology of advanced liver disease and its complications (e.g., hepatocellular carcinoma) has been altered because of a Westernized lifestyle and the implementation of effective vaccination strategies against viral hepatitis. Regional epidemiological patterns of NAFLD indicate that economics, environment, and lifestyle are critical factors in disease progression. The analysis also indicates that a large number of patients remain undiagnosed and untreated because of the inadequacy of diagnostic tools and the absence of effective pharmacologic therapies. Given the burden of NAFLD, future policy and research efforts need to address knowledge gaps to mitigate the risk burden.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zhou J, Zhou F, Wang W, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020. PMID: 32012320. doi:10.1002/hep.31150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。